Preoperative high doses chemoradiotherapy in stage IIIA-N2 NSCLC on behalf of GOECP/SEOR-GICOR

被引：0

作者：

Counago, F. ^{[1
]}

Rodriguez de Dios, N. ^{[2
]}

Montemuno, S. ^{[3
]}

Martin, M. ^{[4
]}

Calvo-Crespo, P. ^{[5
]}

Samper-Ots, M. P. ^{[6
]}

Alcantara, P. ^{[7
]}

Corona, J. ^{[7
]}

Lopez-Guerra, J. L. ^{[8
]}

Murcia-Mejia, M. ^{[9
]}

Lopez-Mata, M. ^{[10
]}

Jove-Teixido, J. ^{[11
]}

Chust, M. ^{[12
]}

Diaz-Diaz, V. ^{[13
]}

De Ingunza-Baron, L. ^{[13
]}

Garcia-Canibano, T. ^{[3
]}

Couselo, M. L. ^{[14
]}

Del Cerro, E. ^{[15
]}

Moradiellos, J. ^{[16
]}

Amor, S. ^{[16
]}

Varela, A. ^{[16
]}

Sanz-Rosa, D. ^{[17
]}

Thuissard, I. J. ^{[17
]}

M, P. M. ^{[16
]}

Taboada, B. ^{[18
]}

机构：

[1] Hosp Univ Quironsalud Madrid, Radiat Oncol, Madrid, Spain

[2] Hosp del Mar, Radiat Oncol, Barcelona, Spain

[3] Hosp Univ Fuenlabrada, Radiat Oncol, Madrid, Spain

[4] Hosp Univ Ramon & Cajal, Radiat Oncol, Madrid, Spain

[5] Complexo Hosp Univ Santiago de Compostela, Radiat Oncol, La Coruna, Spain

[6] Hosp Univ Rey Juan Carlos, Radiat Oncol, Madrid, Spain

[7] Hosp Univ Clin San Carlos, Radiat Oncol, Madrid, Spain

[8] Hosp Univ Virgen del Rocio, Radiat Oncol, Seville, Spain

[9] Hosp Univ St Joan de Reus, Radiat Oncol, Tarragona, Spain

[10] Hosp Clin Univ Lozano Blesa, Radiat Oncol, Zaragoza, Spain

[11] Hosp Badalona Germans Trias & Pujol, Radiat Oncol, Badalona, Spain

[12] Inst Valenciano Oncol, Radiat Oncol, Valencia, Spain

[13] Hosp Univ Puerta del Mar, Radiat Oncol, Cadiz, Spain

[14] Hosp Cent Def Gomez Ulla, Radiat Oncol, Madrid, Spain

[15] Hosp Univ Quironsalud Madrid, Radiat Oncol, Madrid, Spain

[16] Hosp Univ Quironsalud Madrid, Thorac Surg, Madrid, Spain

[17] Univ Europea Madrid, Sch Doctoral Studies & Res, Madrid, Spain

[18] Complexo Hosp Univ Santiago de Compostela, Radiat Oncol, La Coruna, Spain

来源：

RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷

关键词：

D O I：

10.1016/S0167-8140(18)31668-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP-1359

引用

页码：S742 / S743

页数：2

共 50 条

[1] Neoadjuvant Treatment Followed by Surgery Versus Chemoradiation in Stage IIIA-N2 Non-small Cell Lung Cancer on Behalf of GOECP/SEOR-GICOR
Counago, F.
Muniz, S. Montemuino
Jove-Teixido, J.
Taboada, B.
Calvo-Crespo, P.
Martin, M.
Lopez, M.
Ots, P. M. Samper
Del Cerro, E.
Lopez, J.
CaNivano, T. GarcIa
Diaz, V.
Baron, L. De Ingunza
Murcia, M.
Alcantara, M.
Corona, J.
Puertas, M. M.
Chust, M.
Couselo, M. L.
De Dios, N. Rodriguez
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E482 - E483
[2] Trimodality Approach to Stage IIIA-N2 NSCLC: As Good as It Gets?
Bezjak, Andrea
de Perrot, Marc
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1817 - 1818
[3] Clinical Outcome of Stage IIIA-N2(+) NSCLC Patients with Neoadjuvant Chemotherapy
Lee, Hae Won
Hwang, Jin Wook
Baek, Hee Jong
Park, Jong Ho
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S409 - S409
[4] Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
Casiraghi, Monica
Guarize, Juliana
Sandri, Alberto
Maisonneuve, Patrick
Brambilla, Daniela
Romano, Rosalia
Galetta, Domenico
Petrella, Francesco
Gasparri, Roberto
Gridelli, Cesare
De Marinis, Filippo
Spaggiari, Lorenzo
CLINICAL LUNG CANCER, 2019, 20 (02) : 97 - +
[5] The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?
De Ruysscher, Dirk
Vansteenkiste, Johan
Belderbos, Jose
Decaluwe, Herbert
Dingemans, Anne-Marie
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (03) : 284 - 286
[6] Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments
van Meerbeeck, Jan P.
Surmont, Veerle F. M.
LUNG CANCER, 2009, 65 (03) : 257 - 267
[7] The Optimal Choice of Local Therapy for Stage IIIA-N2 NSCLC: Is Radiotherapy Inferior to Surgery?
Nardone, Valerio
Correale, Pierpaolo
Guida, Cesare
ANNALS OF THORACIC SURGERY, 2019, 108 (03): : 961 - 962
[8] The Optimal Choice of Local Therapy for Stage IIIA-N2 NSCLC: Is Radiotherapy Inferior to Surgery? Reply
Zhao, Yi
Liang, Wenhua
He, Jianxing
ANNALS OF THORACIC SURGERY, 2019, 108 (03): : 962 - 963
[9] Long-Term Survival of Stage IIIA-N2 NSCLC Patients with Interstitial Lung Diseases
Watanabe, J.
Horinouchi, H.
Shinno, Y.
Murakami, S.
Goto, Y.
Kanda, S.
Fujiwara, Y.
Yamamoto, N.
Nakamura, Y.
Watanabe, S.
Ohe, Y.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1069 - S1069
[10] Commentary: I Am Happy to Inform You That Thoracotomy Is No Longer Required for Stage IIIA-N2 NSCLC
David, Elizabeth A.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (02) : 558 - 558

← 1 2 3 4 5 →